Skip to main content
  • Indian scientists develop artificial enzyme to keep HIV virus in check

    People suffering from Human Immunodeficiency Virus (HIV) infection can now hope to have a better quality of life with researchers at the Bengaluru-based Indian Institute of Science (IISc) developing a nano alternative to a natural enzyme that is used to block reactivation and replication of the virus in the host’s immune cells.

    admin Tue, 04/06/2021 - 15:51
  • Pioneering method reveals dynamic structure in HIV


    Pharma courses

    pharma courses


  • Anti HIV Medicine can reduce risk of HIV Acquisition


    Pharma courses

    pharma courses


    Pre-exposure prophylaxis (PrEP), a combination drug used to prevent HIV infection, has already gained significant traction in the U.S. and Europe. The once-a-day pill, when taken consistently, can reduce the risk of HIV acquisition by over 85 percent. A new study published in Clinical Infectious Diseases by an international research team suggests that making PrEP available to men who have sex with men (MSM) and people who inject drugs (PWID) in India may be a cost-effective way of curbing the epidemic there.

  • HIV associated with increasing risk of cardiac disease


    Pharma courses

    pharma courses


    People infected with HIV are twice as likely to suffer from heart disease, research has found.

    Analysis of global figures reveals that HIV-associated cardiovascular disease has more than tripled in the past 20 years as more people are living longer with the virus.

  • Clarithromycin Increased Risk of Heart Problems or Death in Patients With Heart Disease: FDA


    Pharma courses

    pharma courses


    FDA is advising caution before prescribing the antibiotic clarithromycin (Biaxin) to patients with heart disease because of a potential increased risk of heart problems or death that can occur years later.

  • Gilead announces Phase 3 Results for Investigational Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for Treatment of HIV


    Pharma courses

    pharma courses


    Gilead Sciences, Inc. announced detailed 48-week results from two Phase 3 studies (Studies 1489 and 1490) evaluating the efficacy and safety of a fixed-dose combination of bictegravir (50 mg) (BIC), a novel investigational integrase strand transfer inhibitor (INSTI), and emtricitabine/tenofovir alafenamide (200/25mg) (FTC/TAF), a dual-NRTI backbone, for the treatment of HIV-1 infection in treatment-naïve adults. In the ongoing studies, BIC/FTC/TAF was found to be statistically non-inferior to regimens containing dolutegravir (50mg) (DTG) in combination with a dual-NRTI backbone. The data were presented in two late-breaker sessions [MOAB01 and TUPDB02] at the 9th IAS Conference on HIV Science (IAS 2017) in Paris.

  • Job Project Coordinator in Regional Institute for HIV Sentinel Surveillance at PGIMER

    Applications are invited for the below mentioned posts under HIV Sentinel Surveillance 2017 (funded by National AIDS Control Organization) on a contractual basis.

    Regional Institute for HIV Sentinel Surveillance; School of Public Health, PGIMER, Chandigarh

    Post : Project Coordinator

  • DCGI relax guidelines for HIV paediatric drugs production


    Pharma courses

    pharma courses


    The Drug Controller General of India (DCGI) on relaxed guidelines for the production of pediatric HIV drugs, whose supply was affected by regulatory issues. The regulator approved the child-friendly and thermally stable pellet formulation of Lopinavir / Ritonavir without feasibility studies, but said it would control post-marketing surveillance.

  • Parliament approve bill to ensure equal rights to people affected by HIV


    Pharma courses

    pharma courses


    Parliament passed the bill to ensure equal rights for people living with HIV and AIDS in treatment, employment and admissions to educational institutions.

  • A STUDY ON ROLE OF DOCTOR OF PHARMACY IN IDENTIFICATION AND REPORTING OF ADVERSE DRUG REACTIONS IN AN ANTIRETROVIRAL THERAPY WARD OF A TERITARY CARE TEACHING HOSPITAL

    { DOWNLOAD AS PDF }

    About Authors:
    M. Manasa Rekha,
    Department of Pharmacy Practice,
    Annamacharya college of Pharmacy,
    Rajampet, Andhra Pradesh,  India.
    manasarekharoyal@gmail.com

    ABSTRACT
    Clinical pharmacy is the branch of pharmacy in which pharmacists provide patient care that optimizes the use of medication and promotes health, wellness, and disease prevention. Clinical pharmacists care for patients in all health care settings but the clinical pharmacy movement initially began inside hospitals and clinics. Clinical pharmacists often work in collaboration with physicians, nurse practitioners and other healthcare professionals. The Clinical Pharmacist Stating explicitly that the clinical pharmacist cares for patients in all health care settings emphasizes two points: that clinical pharmacists provide care to their patients and that this practice can occur in any practice setting. The clinical pharmacist’s application of evidence and evolving sciences points out that clinical pharmacy is a scientifically rooted discipline the application of legal, ethical, social, cultural, and economic principles serves to remind us that clinical pharmacy practice also takes into account societal factors that extend beyond science.

Subscribe to HIV